Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Notes Payables (2017 - 2019)

Historic Notes Payables for Anaptysbio (ANAB) over the last 3 years, with Q4 2019 value amounting to $1.4 million.

  • Anaptysbio's Notes Payables fell 8184.58% to $1.4 million in Q4 2019 from the same period last year, while for Dec 2019 it was $1.4 million, marking a year-over-year decrease of 8184.58%. This contributed to the annual value of $1.4 million for FY2019, which is 8184.58% down from last year.
  • As of Q4 2019, Anaptysbio's Notes Payables stood at $1.4 million, which was down 8184.58% from $3.1 million recorded in Q3 2019.
  • Anaptysbio's 5-year Notes Payables high stood at $7.6 million for Q4 2018, and its period low was $1.2 million during Q1 2017.
  • In the last 3 years, Anaptysbio's Notes Payables had a median value of $5.7 million in 2017 and averaged $5.2 million.
  • As far as peak fluctuations go, Anaptysbio's Notes Payables surged by 50000.0% in 2018, and later crashed by 8184.58% in 2019.
  • Over the past 3 years, Anaptysbio's Notes Payables (Quarter) stood at $6.9 million in 2017, then grew by 10.17% to $7.6 million in 2018, then crashed by 81.85% to $1.4 million in 2019.
  • Its last three reported values are $1.4 million in Q4 2019, $3.1 million for Q3 2019, and $4.8 million during Q2 2019.